BioMarin completes enrollment in phase 2 study of vosoritide for achondroplasia
March 03 2021 - 9:06AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Apr 2024 to May 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From May 2023 to May 2024